Dr. Li is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Medical Oncology and Therapeutics Research
1500 East Duarte Road
Duarte, CA 91010Phone+1 626-256-4673Fax+1 626-301-8233- Is this information wrong?
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2012 - 2015
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2009 - 2012
- Weill Cornell MedicineClass of 2009
Certifications & Licensure
- CA State Medical License 2015 - 2025
- NY State Medical License 2012 - 2017
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study of Efficacy and Safety of PDR001 in Patients With Advanced or Metastatic, Well-differentiated, Non-functional Neuroendocrine Tumors of Pancreatic, Gastrointestinal (GI), or Thoracic Origin or Poorly-differentiated Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC) Start of enrollment: 2017 Feb 14
- IRX-2, Cyclophosphamide, and Nivolumab in Treating Patients With Recurrent or Metastatic and Refractory Liver Cancer Start of enrollment: 2019 Feb 21
Publications & Presentations
PubMed
- Outcome prioritization and preferences among older adults with cancer starting chemotherapy in a randomized clinical trial.Enrique Soto-Perez-de-Celis, William Dale, Vani Katheria, Heeyoung Kim, Marwan Fakih, Vincent M Chung, Dean Lim, Joanne Mortimer, Leana Cabrera Chien, Kemeberly Charle...> ;Cancer. 2024 Apr 17
- Adjuvant Chemoradiation in Resected Biliary Adenocarcinoma: Evaluation of SWOG S0809 with a Large National Database.Dana A Dominguez, Paul Wong, Yi-Jen Chen, Gagandeep P Singh, Yuman Fong, Daneng Li, Philip H G Ituarte, Laleh G Melstrom> ;Annals of Surgical Oncology. 2024 Mar 5
- Acute cancer-related symptoms and concerns among patients receiving chemotherapy: current state of the science.Kristen S Smith, Aasha I Hoogland, Taylor Welniak, Oanh L Nguyen, Yvelise Rodriguez, Xiaoyin Li, Sylvia L Crowder, Laura B Oswald, Kristen M Carpenter, Stacy M Fischer...> ;Supportive Care in Cancer. 2024 Feb 23
- Join now to see all
Journal Articles
- A Phase 2 Multi-Institutional Study of Nivolumab for Patients with Advanced Refractory Biliary Tract CancerOlatunji B Alese, Daneng Li, Amit Mahipal, JAMA Oncology
Authored Content
- A Phase 2 Multi-Institutional Study of Nivolumab for Patients with Advanced Refractory Biliary Tract CancerMay 2020
- A Phase 2 Multi-Institutional Study of Nivolumab for Patients with Advanced Refractory Biliary Tract CancerMay 2020
Press Mentions
- Independence Valued over Survival for Neuroendocrine Tumor PatientsDecember 30th, 2022
- Longer Survival Not Top Priority for Some Patients with CancerDecember 28th, 2022
- First Patient Dosed with Experimental Cancer-Killing Virus in New TrialJune 10th, 2022
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- City of Hope Comprehensive Cancer CenterDuarte, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: